Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
RSI
|
Richard Todd Schwartz
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,419 Reduced 0.18% |
$60,761
$13.75 p/Share
|
Jan 13
2025 |
|
UONE
|
David M Kantor
CEO, Radio Division |
SELL
Open market or private sale
|
Direct | 70,350 Reduced 89.72% |
$68,943
$0.98 p/Share
|
Jan 13
2025 |
|
WEAV
|
Alan Taylor
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 794 Reduced 0.28% |
$12,172
$15.33 p/Share
|
Jan 13
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 39,500 Added 0.0% |
$263,465
$6.67 p/Share
|
Jan 13
2025 |
|
KERN
|
Jessica Billingsley
Director |
BUY
Open market or private purchase
|
Direct | 48,412 Added 49.8% |
$18,880
$0.39 p/Share
|
Jan 13
2025 |
|
AGYS
|
Kaufman 2012 Descendants Trust, David N. Smith, Trustee |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.56% |
$946,950
$126.26 p/Share
|
Jan 13
2025 |
|
ONTF
|
Sharat Sharan
President and Chief Executive |
SELL
Open market or private sale
|
Direct | 36,189 Reduced 1.15% |
$224,371
$6.2 p/Share
|
Jan 13
2025 |
|
ADP
|
Virginia Magliulo
Corp VP |
SELL
Open market or private sale
|
Direct | 3,578 Reduced 28.13% |
$1,021,519
$285.5 p/Share
|
Jan 13
2025 |
|
RGLS
|
Preston Klassen
President & Head of R & D |
SELL
Open market or private sale
|
Direct | 31,445 Reduced 46.59% |
$39,620
$1.26 p/Share
|
Jan 13
2025 |
|
RGLS
|
Crispina Calsada
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 38,716 Reduced 43.36% |
$48,782
$1.26 p/Share
|
Jan 13
2025 |
|
RGLS
|
Joseph P Hagan
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 115,290 Reduced 34.12% |
$145,265
$1.26 p/Share
|
Jan 13
2025 |
|
RGLS
|
Christopher Ray Aker
Sr. VP & General Counsel |
SELL
Open market or private sale
|
Direct | 38,547 Reduced 41.37% |
$48,569
$1.26 p/Share
|
Jan 13
2025 |
|
OCX
|
Patrick W Smith
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,669 Added 0.0% |
$11,791
$2.08 p/Share
|
Jan 13
2025 |
|
IOT
|
John Bicket |
SELL
Open market or private sale
|
Indirect | 42,323 Reduced 0.0% |
$1,833,855
$43.33 p/Share
|
Jan 13
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 29,466 Reduced 0.0% |
$1,917,057
$65.06 p/Share
|
Jan 13
2025 |
|
ENFN
|
Deirdre Somers
Director |
SELL
Open market or private sale
|
Direct | 1,637 Reduced 3.78% |
$17,237
$10.53 p/Share
|
Jan 13
2025 |
|
IOT
|
Sanjit Biswas
CHIEF EXECUTVE OFFICER |
SELL
Open market or private sale
|
Indirect | 56,474 Reduced 0.0% |
$2,447,018
$43.33 p/Share
|
Jan 13
2025 |
|
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Indirect | 1,579 Reduced 0.0% |
$45,080
$28.55 p/Share
|
Jan 13
2025 |
|
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 986 Reduced 1.21% |
$28,150
$28.55 p/Share
|
Jan 13
2025 |
|
JILL
|
Claire Spofford
President & CEO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 3.4% |
$131,800
$26.36 p/Share
|
Jan 13
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 61,000 Added 0.0% |
$447,130
$7.33 p/Share
|
Jan 13
2025 |
|
TDG
|
Kevin M Stein
President & CEO |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$25,262,399
$1263.12 p/Share
|
Jan 13
2025 |
|
KNSA
|
Eben Tessari
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 14,000 Reduced 13.6% |
$260,540
$18.61 p/Share
|
Jan 13
2025 |
|
RM
|
Forager Fund, L.P. |
SELL
Open market or private sale
|
Direct | 21,805 Reduced 2.09% |
$701,466
$32.17 p/Share
|
Jan 13
2025 |
|
IMVT
|
Roivant Sciences Ltd. |
BUY
Open market or private purchase
|
Direct | 16,845,010 Added 14.84% |
$336,900,200
$20.0 p/Share
|
Jan 13
2025 |
|
JELD
|
Turtle Creek Asset Management Inc. |
BUY
Open market or private purchase
|
Indirect | 75,000 Added 0.0% |
$634,500
$8.46 p/Share
|
Jan 13
2025 |
|
BOXL
|
Shaun Marklew
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 885 Reduced 3.2% |
$362
$0.41 p/Share
|
Jan 13
2025 |
|
HRMY
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 7,180 Reduced 100.0% |
$265,947
$37.04 p/Share
|
Jan 13
2025 |
|
TINV-WT
|
Zachary Katz
GC and Head of Global Affairs |
SELL
Open market or private sale
|
Direct | 3,058 Reduced 0.52% |
$50,151
$16.4 p/Share
|
Jan 13
2025 |
|
TCX
|
Elliot Noss
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.02% |
$1,632
$16.32 p/Share
|
Jan 13
2025 |
|
WDAY
|
David A Duffield
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 56,000 Reduced 0.0% |
$13,801,200
$246.45 p/Share
|
Jan 13
2025 |
|
WDAY
|
Mark S. Garfield
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 472 Reduced 1.32% |
$117,169
$248.24 p/Share
|
Jan 13
2025 |
|
DDOG
|
Olivier Pomel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 118,560 Reduced 23.8% |
$16,426,488
$138.55 p/Share
|
Jan 13
2025 |
|
KERN
|
Heather Cox
Director |
BUY
Open market or private purchase
|
Direct | 96,824 Added 41.07% |
$37,761
$0.39 p/Share
|
Jan 13
2025 |
|
BOXL
|
Greg Wiggins
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 169 Reduced 2.12% |
$69
$0.41 p/Share
|
Jan 13
2025 |
|
BOXL
|
Henry Nance
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 575 Reduced 1.38% |
$235
$0.41 p/Share
|
Jan 13
2025 |
|
ADAP
|
Adrian Rawcliffe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,473 Reduced 54.24% |
$17,979
$0.59 p/Share
|
Jan 13
2025 |
|
COIN
|
Brian Armstrong
Chairman and CEO |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 0.0% |
$6,093,750
$243.75 p/Share
|
Jan 13
2025 |
|
VITL
|
Russell Diez Canseco
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 44,628 Reduced 6.26% |
$1,873,037
$41.97 p/Share
|
Jan 13
2025 |
|
VITL
|
Kathryn Mc Keon
CMO and GM, Butter |
SELL
Open market or private sale
|
Direct | 12,300 Reduced 21.02% |
$517,584
$42.08 p/Share
|
Jan 13
2025 |
|
ADAP
|
William C Bertrand Jr
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 9,739 Reduced 56.09% |
$5,746
$0.59 p/Share
|
Jan 13
2025 |
|
KERN
|
Simeon Salzman
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 19,365 Added 9.3% |
$7,552
$0.39 p/Share
|
Jan 13
2025 |
|
ADAP
|
John Lunger
Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct | 9,739 Reduced 56.09% |
$5,746
$0.59 p/Share
|
Jan 13
2025 |
|
KERN
|
Steven D. Gutterman
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 77,459 Added 42.33% |
$30,209
$0.39 p/Share
|
Jan 13
2025 |
|
KERN
|
Daniel George Tolhurst
Director |
BUY
Open market or private purchase
|
Direct | 96,824 Added 2.76% |
$37,761
$0.39 p/Share
|
Jan 13
2025 |
|
ADAP
|
Elliot Norry
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 12,392 Reduced 51.83% |
$7,311
$0.59 p/Share
|
Jan 13
2025 |
|
KERN
|
Peter Eric Gallie
Senior Vice President |
BUY
Open market or private purchase
|
Direct | 145,236 Added 50.0% |
$56,642
$0.39 p/Share
|
Jan 13
2025 |
|
MDB
|
Dwight A Merriman
Director |
SELL
Open market or private sale
|
Indirect | 1,045 Reduced 0.0% |
$253,590
$242.67 p/Share
|
Jan 13
2025 |
|
NTNX
|
Rukmini Sivaraman
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 294 Reduced 0.15% |
$18,095
$61.55 p/Share
|
Jan 13
2025 |
|
BBW
|
Vojin Todorovic
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 16.54% |
$625,950
$41.73 p/Share
|
Jan 13
2025 |